InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Browse the full record of transactions filed by Hahn Mark W, Chief Financial Officer. Director active across 1 companies, notably Verona Pharma plc. In total, 10 reports have been recorded. Total volume traded: €6k. The latest transaction was disclosed on 3 May 2022 — Cession. Regulator: SEC (Form 4). All data is free.
Declarations10 total
€5,89012,512 shares@ €0.47070.1% of flow
Ordinary Shares
SEC:0001104659-22-056606:0·
€214,301432,128 shares@ €0.49594.6% of flow
Ordinary Shares
SEC:0001104659-22-055448:0·
€89,048133,776 shares@ €0.66564.0% of flow
Ordinary Shares
SEC:0001104659-22-011438·
€89,048133,776 shares@ €0.66561.9% of flow
Ordinary Shares
SEC:0001104659-22-011438:0·
€251,891454,848 shares@ €0.553811.4% of flow
Ordinary Shares
SEC:0001104659-21-133855·
€251,891454,848 shares@ €0.55385.4% of flow
Ordinary Shares
SEC:0001104659-21-133855:0·
€300,875454,840 shares@ €0.66156.5% of flow
Ordinary Shares
SEC:0001104659-21-099691:0·
€300,875454,840 shares@ €0.661513.7% of flow
Ordinary Shares
SEC:0001104659-21-099691·
€2m2,122,448 shares@ €0.735870.9% of flow
Ordinary Shares
SEC:0001104659-21-061706·
€2m2,122,448 shares@ €0.735833.8% of flow
Ordinary Shares
SEC:0001104659-21-061706:0·
10 of 10 declarations
About Hahn Mark W
Mark W. Hahn is the Chief Financial Officer at Verona Pharma plc. He oversees the financial management of the company, including financial planning and reporting. With a strong background in the pharmaceutical sector, he plays a key role in formulating financial strategies aimed at supporting Verona Pharma's growth and innovation.
